The many faces of gastrointestinal dysfunction in stiff person syndrome spectrum disorders

被引:2
作者
Koshorek, Jacqueline [1 ]
Wang, Yujie [1 ,2 ]
Maldonado, Daniela Pimentel [1 ]
Reyes-Mantilla, Maria I. [1 ]
Obando, Danielle [1 ]
Balshi, Alexandra [1 ]
Comisac, Michael [1 ]
Pasricha, Pankaj Jay [3 ,4 ]
Newsome, Scott D. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[2] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA
[3] Johns Hopkins Sch Med, Dept Gastroenterol, Baltimore, MD USA
[4] Mayo Clin Arizona, Dept Med, Scottsdale, AZ USA
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
stiff person spectrum disorder; GAD65; antibodies; GI dysmotility; gastrointestinal dysfunction; stiff person syndrome; MOTILITY; GABA;
D O I
10.3389/fneur.2023.1273256
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The effect of stiff person syndrome spectrum disorders (SPSD) on the gastrointestinal tract (GIT) is unknown. This case series aims to characterize the prevalence and types of GI dysfunction in individuals with SPSD.Methods A retrospective chart review included individuals diagnosed with SPSD with descriptors of GI symptoms in their medical records. SPSD phenotypes, type of motility test performed, and dysmotility pattern (upper, lower, or diffuse) were assessed. Descriptive statistics and univariate chi-square analyses were utilized.Results Of 240 individuals with SPSD, 32% reported GI symptoms, most were female (83.1%), and white (74%), with a median age at time of GI symptom onset of 50 +/- 13 years. Most common symptoms reported were dysphagia (45%), constipation (40%), and nausea/vomiting (23%). Most individuals had classic SPS (47%) followed by SPS-plus (29%) and 82.9% were positive for serum antiGAD65 antibodies. Of 36 patients that underwent at least one GI motility test, 26 had evidence of upper, lower, or diffuse GI dysmotility (44.4%, 17%, and 4%, respectively). The group who did not undergo testing had a higher proportion of patients with DM.Discussion There is a high prevalence of GI symptoms and transit abnormalities in patients with SPSD. Future prospective, longitudinal studies are warranted to further assess GI symptoms in the context of SPSD and to determine if individuals with GI symptoms differ in prognosis or treatment response from those without GI symptoms. In the meantime, there should be a low threshold for motility testing in patients with SPSD.
引用
收藏
页数:4
相关论文
共 10 条
  • [1] Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome
    Aggarwal, Surbhi
    Ahuja, Vineet
    Paul, Jaishree
    [J]. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (03) : 422 - 430
  • [2] GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation
    Auteri, Michelangelo
    Zizzo, Maria Grazia
    Serio, Rosa
    [J]. PHARMACOLOGICAL RESEARCH, 2015, 93 : 11 - 21
  • [3] Bounds CG., 2022, StatPearls
  • [4] Castedal M, 2000, ALIMENT PHARM THER, V14, P571
  • [5] Crispo James A G, 2018, J Clin Mov Disord, V5, P5, DOI 10.1186/s40734-018-0071-9
  • [6] The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome
    Dalakas, MC
    Fujii, M
    Li, M
    McElroy, B
    [J]. NEUROLOGY, 2000, 55 (10) : 1531 - 1535
  • [7] Ghanavatian S, 2022, STATPEARLS
  • [8] Krantis A, 2000, NEWS PHYSIOL SCI, V15, P284
  • [9] Stiff-Man Syndrome and Variants
    McKeon, Andrew
    Robinson, Maisha T.
    McEvoy, Kathleen M.
    Matsumoto, Joseph Y.
    Lennon, Vanda A.
    Ahlskog, J. Eric
    Pittock, Sean J.
    [J]. ARCHIVES OF NEUROLOGY, 2012, 69 (02) : 230 - 238
  • [10] AUTOANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE IN A PATIENT WITH STIFF-MAN SYNDROME, EPILEPSY, AND TYPE-I DIABETES-MELLITUS
    SOLIMENA, M
    FOLLI, F
    DENISDONINI, S
    COMI, GC
    POZZA, G
    DECAMILLI, P
    VICARI, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (16) : 1012 - 1020